PRMT9 and hepatocellular carcinoma: Their subsequent research found that PRMT9 inhibits ferroptosis to accelerate hepatitis B virus‐associated hepatocellular carcinoma progression by promoting the arginine methylation of heat shock protein 8 (HSPA8) [6].